155 results on '"Zarkali, Angeliki"'
Search Results
2. Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson’s Disease
3. The neural correlates of visual hallucinations in Parkinson's disease
4. Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
5. Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes
6. Evaluation of START (STrAtegies for RelaTives) adapted for carers of people with Lewy body dementia
7. Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease
8. Atrial Fibrillation: An Underestimated Cause of Ischemic Monocular Visual Loss?
9. Neuroimaging and plasma marker evidence for white matter macrostructure loss in Parkinson’s disease
10. Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
11. Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction
12. Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson’s disease
13. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis
14. Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson’s disease
15. Why are trainees not choosing general practice?
16. PO264 Prevalence of atrial fibrilation in 395 patients presenting with ocular ischaemic events
17. PO160 Atypical transverse myelitis in a patient with newly diagnosed hepatitis c: a case report and review of the literature
18. PO161 Catastrophic arachnoiditis following posterior fossa aneurysmal subarachnoid haemorrhage
19. 1115 Undertreatment of vascular risk factors in patients presenting with ischaemic ocular events: results from 395 patients in a tertiary centre
20. Neurofilament light-associated connectivity in young-adult Huntington’s disease is related to neuronal genes
21. Using network approaches to unravel the mysteries of visual hallucinations in Lewy body dementia
22. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis
23. Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis.
24. Clinician burnout: results of an ABN survey of British neurologists
25. 187 Variation in training: Results from a survey of UK neurology trainees
26. 189 Association of British Neurology trainees: biennial national census
27. 128 White matter fibre loss in Parkinson’s disease hallucinations
28. 129 Network controllability and regional gene expression explain visual hallucinations in Parkinson’s
29. Visual dysfunction predicts cognitive impairment and white matter degenera- tion in Parkinson’s disease
30. Fixel‐based analysis of the effect of amyloid beta on white matter tracts in neurologically normal 70 year olds
31. Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson's disease.
32. Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease
33. Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
34. Beyond dopamine: Further evidence of cholinergic dysfunction in Parkinson's disease (Commentary on Keo et al., 2021)
35. Review for "Cingulate networks associated with gray matter loss in Parkinson’s disease show high expression of cholinergic genes in the healthy brain"
36. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease
37. Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease
38. Review for "Cingulate networks associated with gray matter loss in Parkinson’s disease show high expression of cholinergic genes in the healthy brain"
39. Differences in network controllability and regional gene expression underlie hallucinations in Parkinson’s disease
40. Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson’s disease
41. Dementia risk in Parkinson’s disease is associated with interhemispheric connectivity loss and determined by regional gene expression
42. Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's disease.
43. Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson's Disease
44. Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson’s Disease
45. 42 Multi-agent allergies as predictor of functional neurological disorder
46. Increased weighting on prior knowledge in Lewy body-associated visual hallucinations
47. Glial fibrillary acidic protein antibody-positive meningoencephalomyelitis
48. Undertreatment of Vascular Risk Factors in Patients with Monocular Ischaemic Visual Loss
49. The changing landscape of Disease Modifying Treatments: cost implications for healthcare systems
50. PREVALENCE OF ATRIAL FIBRILATION IN 395 PATIENTS PRESENTING WITH TRANSIENT AND PERMANENT OCULAR ISCHAEMIC EVENTS IN A TERTIARY LONDON CENTRE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.